These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 32274571)
21. Emerging therapies with potential risks of medicine-related osteonecrosis of the jaw: a review of the literature. Kanwar N; Bakr MM; Meer M; Siddiqi A Br Dent J; 2020 Jun; 228(11):886-892. PubMed ID: 32541753 [TBL] [Abstract][Full Text] [Related]
22. "Spontaneous" medication-related osteonecrosis of the jaw; two case reports and a systematic review. Khominsky A; Lim M Aust Dent J; 2018 Dec; 63(4):441-454. PubMed ID: 30144095 [TBL] [Abstract][Full Text] [Related]
23. Bisphosphonate-associated osteonecrosis of jaw reoccurrence after methotrexate therapy: a case report. Alsalleeh F; Keippel J; Adams L; Bavitz B J Endod; 2014 Sep; 40(9):1505-7. PubMed ID: 25146044 [TBL] [Abstract][Full Text] [Related]
24. Osteonecrosis of the jaws: a 14-year retrospective survey of hospital admissions. McGowan K; Ivanovski S; Acton C Aust Dent J; 2018 Jun; 63(2):202-207. PubMed ID: 29432652 [TBL] [Abstract][Full Text] [Related]
25. Oral cutaneous sinus tract, vertical root fracture, and bisphosphonate-related osteonecrosis: a case report. Wigler R; Steinbock N; Berg T J Endod; 2013 Aug; 39(8):1088-90. PubMed ID: 23880284 [TBL] [Abstract][Full Text] [Related]
26. Medication-Related Osteonecrosis of the Jaws. Migliorati CA; Brennan MT; Peterson DE J Natl Cancer Inst Monogr; 2019 Aug; 2019(53):. PubMed ID: 31425596 [TBL] [Abstract][Full Text] [Related]
27. Retrospective Audit: Does Prior Assessment by Oral and Maxillofacial Surgeons Reduce the Risk of Osteonecrosis of The Jaw in Patients Receiving Bone-Targeted Therapies for Metastatic Cancers to the Skeleton?--Part II. Turner B; Ali S; Pati J; Nargund V; Ali E; Cheng L; Wells P Urol Nurs; 2016; 36(3):117-22, 132. PubMed ID: 27501592 [TBL] [Abstract][Full Text] [Related]
28. The influence of alendronate and tooth extraction on the incidence of osteonecrosis of the jaw among osteoporotic subjects. Chiu WY; Yang WS; Chien JY; Lee JJ; Tsai KS PLoS One; 2018; 13(4):e0196419. PubMed ID: 29694412 [TBL] [Abstract][Full Text] [Related]
29. [Clinical analysis of 24 cases of bisphosphonate-related osteonecrosis of the jaw]. Guo Y; Wang D; An J; Peng X; Cai Z; Guo C Zhonghua Kou Qiang Yi Xue Za Zhi; 2014 Sep; 49(9):517-20. PubMed ID: 25476210 [TBL] [Abstract][Full Text] [Related]
30. Antiresorptive Agent-Related Osteonecrosis of the Jaw (ARONJ): A Twist of Fate in the Bone. Shibahara T Tohoku J Exp Med; 2019 Feb; 247(2):75-86. PubMed ID: 30713280 [TBL] [Abstract][Full Text] [Related]
31. Evaluation of Preventive Treatment Protocols for Patients under Antiresorptive Therapy Undergoing Tooth Extraction at a Swiss University Clinic. Pick E; Leuenberger N; Kuster I; Stutzmann NS; Stadlinger B; Valdec S Int J Environ Res Public Health; 2021 Sep; 18(18):. PubMed ID: 34574862 [TBL] [Abstract][Full Text] [Related]
32. Primary wound closure and perioperative antibiotic therapy for prevention of bisphosphonate-related osteonecrosis of the jaw after tooth extraction. Spanou A; Nelson K; Ermer MA; Steybe D; Poxleitner P; Voss PJ Quintessence Int; 2020; 51(3):220-228. PubMed ID: 32020132 [TBL] [Abstract][Full Text] [Related]
33. Risk of Delayed Healing of Tooth Extraction Wounds and Osteonecrosis of the Jaw among Patients Treated with Potential Immunosuppressive Drugs: A Retrospective Cohort Study. Hayashi M; Morimoto Y; Iida T; Tanaka Y; Sugiyama S Tohoku J Exp Med; 2018 Dec; 246(4):257-264. PubMed ID: 30568073 [TBL] [Abstract][Full Text] [Related]
34. Dental pathologies in tumor patients with bone metastases or multiple myeloma scheduled for antiresorptive therapy. Laimer J; Hechenberger M; Müller D; Walch B; Kolk A; Schnabl D; Schomaker M; Bruckmoser E Future Oncol; 2021 Jul; 17(21):2705-2711. PubMed ID: 33880956 [No Abstract] [Full Text] [Related]
35. Primary wound closure after tooth extraction for prevention of medication-related osteonecrosis of the jaw in patients under denosumab. Matsumoto A; Sasaki M; Schmelzeisen R; Oyama Y; Mori Y; Voss PJ Clin Oral Investig; 2017 Jan; 21(1):127-134. PubMed ID: 26924135 [TBL] [Abstract][Full Text] [Related]
36. Pharmacovigilance and reporting oversight in US FDA fast-track process: bisphosphonates and osteonecrosis of the jaw. Edwards BJ; Gounder M; McKoy JM; Boyd I; Farrugia M; Migliorati C; Marx R; Ruggiero S; Dimopoulos M; Raisch DW; Singhal S; Carson K; Obadina E; Trifilio S; West D; Mehta J; Bennett CL Lancet Oncol; 2008 Dec; 9(12):1166-72. PubMed ID: 19038763 [TBL] [Abstract][Full Text] [Related]
37. Relationships of opacification in the nasal sinuses, rhinosinusitis, and antiresorptive agent-related osteonecrosis of the jaw. Matsumoto Y; Yokoi H; Ikeda T; Kawada M; Saito K Auris Nasus Larynx; 2020 Dec; 47(6):996-1002. PubMed ID: 32591168 [TBL] [Abstract][Full Text] [Related]
38. Osteonecrosis of the jaw in Sweden associated with the oral use of bisphosphonate. Ulmner M; Jarnbring F; Törring O J Oral Maxillofac Surg; 2014 Jan; 72(1):76-82. PubMed ID: 23992777 [TBL] [Abstract][Full Text] [Related]
39. Methotrexate-associated osteonecrosis of the jaw: A report of two cases. Henien M; Carey B; Hullah E; Sproat C; Patel V Oral Surg Oral Med Oral Pathol Oral Radiol; 2017 Dec; 124(6):e283-e287. PubMed ID: 29056286 [TBL] [Abstract][Full Text] [Related]
40. Diagnosis and Staging of Medication-Related Osteonecrosis of the Jaw. Ruggiero SL Oral Maxillofac Surg Clin North Am; 2015 Nov; 27(4):479-87. PubMed ID: 26293329 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]